France· FR:69588545
SCOBUREN 20 mg/mL, solution injectable en ampoule
A medicinal product containing butylbromure de scopolamine, registered in France by LABORATOIRE RENAUDIN, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BUTYLBROMURE DE SCOPOLAMINE
- Manufacturer
- LABORATOIRE RENAUDIN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093515928110 ampoule(s) en verre de 1 mlEUR 12.41
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Butylbromure de scopolamine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsBuscopan, injectievloeistof 20 mg/mlEuro Registratie Collectief B.V.
- United KingdomBuscopan 10mg tabletsDowelhurst Ltd
- BelgiumBuscafor 10 mg - 500 mgUPSA
- GermanyBuscopanA. Nattermann & Cie. Gmbh
- FinlandBumacorMacure Pharma ApS
- SwedenBumacor 20 mg/ml Injektionsvätska, lösningMACURE PHARMA ApS
- CzechiaBUSCOPANMayoly Pharma France, Rueil-Malmaison
- NorwayBumacorMacure Pharma ApS
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Buscapina, Buscopan
- Belgium · Buscopan, Buscopan Forte
- Bulgaria · Бусколизин, Бусколизин Форте
- Cyprus · Avotrin, Buscopan
- Czechia · Buscopan, Butylskopolaminium Bromid Kalceks
- Germany · Buscopan, Buscopan Ampullen
- Denmark · Bumacor
- Estonia · Bysimin
- Spain · Buscapina, Buscopresc
- Finland · Bumacor, Buscopan
- United Kingdom (Northern Ireland) · Almus Ibs Relief, Almus Stomach Cramp Relief
- Greece · Avotrin, Buscopan
- Croatia · Buscopan, Bysimin
- Hungary · Buscopan, Buscopan Forte
- Ireland · Buscopan, Buscopan Ampoules
- Italy · Addofix, Buscopan
- Luxembourg · Buscopan, Buscopan Forte
- Latvia · Buscopan, Hyoscine Butylbromide Kalceks
- Malta · Buscopan, Buscopan Ampoules
- Netherlands · Buscopan, Scopolamine Butylbromide Kalceks
- Norway · Bumacor, Buscopan
- Poland · Aurogastro, Buscolysin
- Portugal · Buscopan, Butilescopolamina Conforpam
- Romania · Buscopan, Buscotil
- Sweden · Bumacor, Buscopan
- Slovenia · Buscopan
- Slovakia · Buscopan, Scopolamine Butylbromide Kalceks
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2d0c5af0-a3c0-49a8-aa19-a387966e63db GET /v1/drugs/2d0c5af0-a3c0-49a8-aa19-a387966e63db?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69588545",
"date_amm": "1999-06-22",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "BUTYLBROMURE DE SCOPOLAMINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intramusculaire;intraveineuse;sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about butylbromure de scopolamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.